
- Pharmaceutical Technology-08-02-2015
- Volume 39
- Issue 8
Syringe Closure System Allows Use of Highly Sensitive Compounds
Vetter’s Vetter-Ject closure system for prefilled syringes has an integrated needle hub and shield and is designed for sensitive compounds, such as biologics.
Vetter’s Vetter-Ject closure system for prefilled syringes has an integrated needle hub and shield and is designed for sensitive compounds, such as biologics. The system’s baked-in siliconization process for the glass barrel allows the silicon content to be customized. The percentage of silicon used can be reduced up to 80% compared to standard siliconization processes used in conventional syringe systems, which makes the system suitable for silicon-sensitive drug products. The closure is tamper-evident; plastic bridges are broken when the needle shield is removed. The system can be used with a wide range of primary packaging options, such as stoppers and glass barrels.
Vetter Pharma International GmbH
Articles in this issue
over 10 years ago
Getting Comfortable With Leanover 10 years ago
Black Specks in Tablet Stability Samplesover 10 years ago
Environmental Containment Performance—Is There Accountability?over 10 years ago
Implementing Electronic Production Recordsover 10 years ago
Understanding Risks in Pharmaceutical Shippingover 10 years ago
Outsourcing Becoming More Cost Competitiveover 10 years ago
Regulation of Medical Devices and Companion Diagnosticsover 10 years ago
Campaign Against Fake Drugs Gains Momentumover 10 years ago
Defining Crucial CAPA Componentsover 10 years ago
Taking the Pulse of Manufacturing Trends and Equipment UseNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.




